ArticlePharmaceutics2023

Investigating the Targeting Power to Brain Tissues of Intranasal Rasagiline Mesylate-Loaded Transferosomal In Situ Gel for Efficient Treatment of Parkinson's Disease.

Hala N ElShagea et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.